COWAN CHAD (Chief Scientific Officer) reported 1 transaction at CENTURY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/15/2026ACC: 0002039294-26-000010
Officer· Chief Scientific Officer
Since Mar 2026
-358.00
Net shares
Net seller
$801.92
Total sold
0
Open market trades
0B · 0S
1
Total transactions
358.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−358.00
Price / share
$2.24
Trade value
$801.92
% of position
0.0%
6/11/2026
1.18M→1.18M
Total
Net shares
−358.00
Net value
-$801.92
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | F · Tax Withholding | −358.00 | $2.24 | $801.92 | 0.0% | 1.18M | 1.18M |
| Total | −358.00 | -$801.92 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.70K
Total
10.70K indirect10.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.70K | Indirect |
| Total | 10.70K | 10.70K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported